Tuberous sclerosis

Handbook of Clinical Neurology

Volumn 87, Issue , 2007, Pages 129-151

  Curatolo, Paolo ^a   Bombardieri, Roberta ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERIN; TUBEROUS SCLEROSIS COMPLEX 1 PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL; BRAIN; GENETICS; HISTORY; HUMAN; METABOLISM; METHODOLOGY; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REVIEW; TUBEROUS SCLEROSIS;

ANIMALS; BRAIN; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; MAGNETIC RESONANCE IMAGING; NERVOUS SYSTEM DISEASES; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 67649387128     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)87009-6     Document Type: Review

References (116)

1. Alkalay A.L., Ferry D.A., Lin B., et al. Spontaneous regression of cardiac rhabdomyoma in tuberous sclerosis. Clin Pediatr (Phila) 26 (1987) 532-535
2. Arai Y., Takashima S., and Becker L.E. CD44 expression in tuberous sclerosis. Pathobiology 68 (2000) 87-92
3. Au K., Williams A.T., Gambello M.J., et al. Molecular genetic basis of the tuberous sclerosis complex: from bench to bedside. J Child Neurol 19 (2004) 699-709
4. Baron Y., and Barkovich A.J. MR imaging of tuberous sclerosis in neonates and young infants. Am J Neuroradiol 20 (1999) 907-916
5. Bolton P.F. Intellectual and cognitive impairments. In: Curatolo P. (Ed). Tuberous Sclerosis Complex: From Basic Science to Clinical Phenotypes (2003), Cambridge University Press, Cambridge 77-90
6. Bozzao A., Manenti G., and Curatolo P. Neuroimaging. In: Curatolo P. (Ed). Tuberous Sclerosis Complex: From Basic Science to Clinical Phenotypes (2003), Cambridge University Press, Cambridge 109-123
7. Bourneville D.M. Sclérose tubéreuse des circonvolutions cérébrales: idiotie et épilepsie hémiplégique. Arch Neurol (Paris) 1 (1880) 81-91
8. Bourneville D.M., and Brissaud E. Encéphalite ou sclérose tubéreuse des circonvolution cérébrales. Arch Neurol (Paris) 1 (1881) 390-410
9. Bruni O., Cortesi F., Curatolo P., et al. Sleep disorders in tuberous sclerosis: a polysomnographic study. Brain Dev 17 (1995) 52-56
10. Carbonara C., Longa L., Grosso E., et al. 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene. Hum Mol Genet 3 (1994) 1829-1832
11. Chiron C., Dulac O., Beaumont D., et al. Therapeutic trial of vigabatrin in refractory infantile spasms. J Child Neurol 6 (1991) 2552-2559
12. Chiron C., Dumas C., Jambaque I., et al. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res 26 (1997) 389-395
13. Collins J.J., Tudor C., Leonard J.M., et al. Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trial. J Child Neurol 21 (2006) 53-57
14. A receptor plasticity by progesterone metabolites. Eur J Pharmacol 375 (1999) 225-235
15. Crino P.B. Molecular neurobiology. In: Curatolo P. (Ed). Tuberous Sclerosis Complex: From Basic Science to Clinical Phenotypes (2003), Cambridge University Press, Cambridge 279-295
16. Crino P.B. Molecular pathogenesis of tuber formation in tuberous sclerosis complex. J Child Neurol 19 9 (2004) 716-725
17. Crino P.B., Dichter M.A., Trojanowski J.Q., et al. Embryonic neuronal markers in tuberous sclerosis: single cell molecular pathology. Proc Natl Acad Sci USA 93 (1996) 14152-14157
18. Curatolo P. Tuberous Sclerosis Complex: From Basic Science to Clinical Phenotypes (2003), Cambridge University Press, Cambridge
19. Curatolo P., and Verdecchia M. Neurological manifestations. In: Curatolo P. (Ed). Tuberous Sclerosis Complex: From Basic Science to Clinical Phenotypes (2004), Cambridge University Press, Cambridge 26-45
20. Curatolo P., Cusmai R., Cortesi F., et al. Neurologic and psychiatric aspects of tuberous sclerosis. Ann N Y Acad Sci 615 (1991) 8-16
21. Curatolo P., Seri S., Verdecchia M., et al. Infantile spasms in tuberous sclerosis complex. Brain Dev 173 (2001) 502-507
22. Curatolo P., Verdecchia M., and Bombardieri R. Vigabatrin for tuberous sclerosis. Brain Dev 23 (2001) 649-653
23. Curatolo P., Verdecchia M., and Bombardieri R. Tuberous sclerosis complex: a review of neurological aspects. Eur J Paediatr Neurol 6 (2002) 15-23
24. Curatolo P., Bombardieri R., and Cerminara C. Current management for epilepsy in tuberous sclerosis complex. Curr Opin Neurol 19 (2006) 119-123
25. Curatolo P., Bombardieri R., Verdecchia M., et al. Intractable seizures in tuberous sclerosis complex: from molecular pathogenesis to the rational for treatment. J Child Neurol 20 (2005) 318-325
26. Dabora S.L., Jozwiak S., Franz D.N., et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2 compared with TSC1 disease in multiple organs. Am J Hum Genet 68 (2001) 64-80
27. Daniels R.J., Peden J.F., and Lloyd C. Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16. Hum Mol Genet 10 (2001) 339-352
28. De Vries P.J., Humphrey A., and McCartney D. Consensus clinical guidelines for the assessment of cognitive and behavioural problems in tuberous sclerosis. Eur Child Adolesc Psychiatry 14 (2005) 183-190
29. De Vries P.J., Scott C.M., and Bolton P.F. Specific cognitive deficits in adults with tuberous sclerosis. J Child Neurol 16 (2001) 676
30. DiMario F.J., Diana D., Leopold H., et al. Evolution of cardiac rhabdomyoma in tuberous sclerosis complex. Clin Pediatr (Phila) 12 (1996) 615-619
31. DiMario Jr. F.J. Brain abnormalities in tuberous sclerosis complex. J Child Neurol 19 (2004) 650-657
32. A receptor active steroids are altered in epileptic patients with tuberous sclerosis. J Neurol Neurosurg Psychiatry 74 (2003) 667-670
33. Elterman R.D., Shields W.D., Mansfield K.A., et al., US Infantile Spasms Vigabatrin Study Group. Randomized trial of vigabatrin in patients with infantile spasms. Neurology 57 (2001) 1416-1421
34. European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75 (1993) 1-11
35. Ewalt D.E., Sheffield E., Sparagana S.P., et al. Renal lesion growth in children with tuberous sclerosis complex. J Urol 160 (1998) 141-145
36. Franz D.N. Non-neurologic manifestations of tuberous sclerosis complex. J Child Neurol 19 (2004) 690-698
37. Franz D.N., Leonard J., Tudor C., et al. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol 59 (2006) 490-498
38. Gibbs J.L. The heart and tuberous sclerosis. An echocardiographic and electrocardiographic study. Br Heart J 54 (1985) 596-599
39. Gomez M.R. Tuberous Sclerosis. 2nd edn. (1979), Raven Press, New York
40. Goodman M., Lamm S.H., Engel A., et al. Cortical tuber count: a biomarker indicating cerebral severity of tuberous sclerosis complex. J Child Neurol 12 (1997) 85-90
41. Green A.J., Johnson P.H., and Yates J.R.W. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. Hum Mol Genet 3 (1994) 1833-1834
42. Green A.J., Smith M., and Yates J.R.W. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet 6 (1994) 193-196
43. Griffiths P.D., and Martland T.R. Tuberous sclerosis complex: the role of neuroradiology. Neuropediatrics 28 (1997) 244-252
44. Gunther M., and Penrose L.S. The genetics of epiloia. J Genet 31 (1935) 413-430
45. Harding G.F., Spencer E.L., Wild J.M., et al. Field-specific visual-evoked potentials: identifying field defects in vigabatrin-treated children. Neurology 58 (2002) 1261-1265
46. Harrison J., O'Callaghan F., Hancock E., et al. Cognitive deficits in normally intelligent patients with tuberous sclerosis. Am J Med Genet 88 (1999) 642-646
47. Henske E., Scheithauer B., Short M., et al. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet 59 (1996) 400-406
48. Hirose Y., Scheithauer B.W., Lopes M.B.S., et al. Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron microscopic study. Acta Neuropathol 90 (1995) 387-399
49. Hosoya M., Naito H., and Nihei K. Neurological prognosis correlated with variations over time in the number of subependymal nodules in tuberous sclerosis. Brain Dev 21 (1999) 544-547
50. Houser W.O., Shepherd C.W., and Gomez M.R. Imaging of intracranial tuberous sclerosis. Ann NY Acad Sci 615 (1991) 81-93
51. Hunt A., and Dennis J. Psychiatric disorders among children with tuberous sclerosis. Dev Med Child Neurol 29 (1987) 190-198
52. Jambaque I., Chiron C., Dumas C., et al. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients. Epilepsy Res 38 (2000) 151-160
53. Joinson C., O'Callagan F., Osborne J., et al. Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex. Psychol Med 33 (2003) 335-344
54. Jones A.C., Daniells C.E., Snell R.G., et al. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. Hum Mol Genet 6 (1997) 2155-2161
55. Jones A.C., Shyamsundar M.M., Thomas M.W., et al. Comprehensive mutation analysis of TSC1 and TSC2 and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet 64 (1999) 1305-1315
56. Jozwiak S. Ophtalmological manifestations. In: Curatolo P. (Ed). Tuberous Sclerosis Complex: From Basic Science to Clinical Phenotypes (2003), Cambridge University Press, Cambridge 170-179
57. Jozwiak S., Kawalec W., Dluzewska J., et al. Cardiac tumors in tuberous sclerosis: their incidence and course. Eur J Pediatr 153 (1994) 155-157
58. Jozwiak S., Kwiatkowska D.J., Kasprzyk-Obara J., et al. Epilepsy and especially infantile spasms are more frequent among patients with TSC2 mutations. J Child Neurol 16 (2001) 675
59. Jozwiak S., Goodman M., and Lamm S.H. Poor mental development in patients with tuberous sclerosis complex. Clinical risk factors. Arch Neurol 55 (1998) 379-384
60. Jozwiak J., Kotulska K., and Jozwiak S. Similarity of balloon cells in focal cortical dysplasia to giant cells in tuberous sclerosis. Epilepsia 47 (2006) 805
61. Kandt R.S., Haines J.L., Smith M., et al. Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet 2 (1992) 37-41
62. Karbowniczek M., Cash T., Cheung M., et al. Regulation of B-Raf kinase activity by tuberin and Rheb is mammalian target of rapamycin (mTOR)-independent. J Biol Chem 279 (2004) 29930-29937
63. Kiribuchi K., Uchida Y., Fukuyama Y., et al. High incidence of fundus hamartomas and clinical significance of a fundus score in tuberous sclerosis. Brain Dev 8 (1986) 509-517
64. Kwiatkowska J., Jozwiak S., Hall F., et al. Comprehensive analysis of the TSC1 gene: observations on frequency of mutation, associated features, and nonpenetrance. Ann Hum Genet 62 (1998) 277-285
65. Kwiatkowski D., Reeve M.P., Cheadle J.P., et al. Molecular genetics. In: Curatolo P. (Ed). Tuberous Sclerosis Complex: From Basic Science to Clinical Phenotypes (2004), Cambridge University Press, Cambridge 228-263
66. Inoe Y., Nemoto Y., Murata R., et al. CT and MR imaging of cerebral tuberous sclerosis. Brain Dev 20 (1998) 209-221
67. Lagos J.C., and Gomez M.R. Tuberous sclerosis: reappraisal of a clinical entity. Mayo Clin Proc 42 (1967) 26-49
68. Lamb R.F., Roy C., Diefenbach T.J., et al. The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nat Cell Biol 2 (2000) 281-287
69. Lazarowski A., Lubieniecki F., Camarero S., et al. Multidrug resistance proteins in tuberous sclerosis and refractory epilepsy. Pediatr Neurol 30 (2004) 102-106
70. Lee L., Sudentas P., Donohue B., et al. Efficacy of a rapamycin analogue (CCI-779) and IFN-gamma in tuberous sclerosis mouse models. Genes Chromosomes Cancer 42 (2005) 213-227
71. Lippa C.F., Pearson D., and Smith T.W. Cortical tubers demonstrate reduced immunoreactivity for synapsin I. Acta Neuropath 85 (1993) 449-451
72. Lopes M.B.S., Altermatt H.J., Scheitauer B.W., et al. Immunohistochemical characterization of subependymal giant cell astrocytomas. Acta Neuropath 91 (1996) 368-375
73. Lucarelli P., Palminiello S., Curatolo P., et al. Association study of the autistic disorder and chromosome 16p. Am J Med Genet 119A: 24 (2003) 2-246
74. Moolten S.E. Hamartial nature of the tuberous sclerosis complex and its bearing on the tumour problem: report of one case with tumour anomaly of the kidney and adenoma sebaceum. Arch Intern Med 69 (1942) 589-623
75. Nabbout R., Santos M., Rolland Y., et al. Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis. J Neurol Neurosurg Psychiatry 66 (1999) 370-375
76. Nellist M., van Slegtenhorst M.A., Goedbloed M., et al. Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin. J Biol Chem 274 (1999) 35647-35652
77. Niida Y., Lawrence-Smith N., Banwell A., et al. Analysis of both TSC1 and TSC2 for germiline mutations in 126 unrelated patients with tuberous sclerosis. Hum Mutat 14 (1999) 412-422
78. Niida Y., Lawrence-Smith N., Banwell A., et al. Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Am J Hum Genet 69 (2001) 493-503
79. Normann S., Green A.J., von Bakel I., et al. Tuberous sclerosis-like lesions in epileptogenic human neocortex lack allelic loss at the TSC1 and TSC2 regions. Acta Neuropathol (Berl) 93 (1997) 93-96
80. Park S.H., Pepkowitz S.H., Kerfoot C., et al. Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study. Acta Neuropathol (Berl) 94 (1997) 180-186
81. Pellizzi G.B. Contributo allo studio dell'idiozia. Riv Sper Freniatr Med Leg Alien Ment 27 (1901) 265-269
82. Povey S., Burley M.W., Attwood J., et al. Two loci for tuberous sclerosis: one on 9q34 and one on 16p13. Ann Hum Genet 58 (1994) 107-127
83. Prather P., and de Vries P.J. Behavioural and cognitive aspects of tuberous sclerosis complex. J Child Neurol 19 (2004) 666-674
84. Reid C.B., Liang I., and Walsh C. Systematic widespread clonal organization in cerebral cortex. Neuron 15 (1995) 299-310
85. Roach E.S., and Sparagana S.P. Diagnosis of tuberous sclerosis complex. J Child Neurol 19 (2004) 643-649
86. Roach E.S., Gomez M.R., and Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 13 (1998) 624-628
87. Robinson P.D., Schutz C.K., Macciardi F., et al. Genetically determined low maternal serum dopamine beta-hydroxilase levels and the etiology of autism spectrum disorders. Am J Med Genet 100 (2001) 30-36
88. Romanelli P., Verdecchia M., Rodas R., et al. Epilepsy surgery for tuberous sclerosis. Pediatr Neurol 31 (2004) 239-247
89. Rose V.M., Au K., Pollon G., et al. Germline mosaicism in tuberous sclerosis: how common. Am J Hum Genet 64 (1999) 986-992
90. Sancak O., Nellist M., Goedbloed M., et al. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype-phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex. Eur J Hum Genet 13 (2005) 695-696
91. Scheidenhelm D.K., and Gutmann D.H. Mouse models of tuberous sclerosis complex. J Child Neurol 19 (2004) 726-733
92. Scheithauer B.W., and Reagan T.J. Neuropathology in the tuberous sclerosis complex. In: Gomez M.R., Sampson J.R., and Whittemore V.H. (Eds). Tuberous Sclerosis Complex. 3rd edn (1999), Oxford University Press, New York 101-121
93. Seri S., Cerquiglini A., Pascual Marqui, et al. Frontal lobe epilepsy: EEG-MRI fusioning. J Child Neurol 13 (1998) 34-38
94. Shepherd C.W., Houser O.W., and Gomez M.R. MR findings in tuberous sclerosis complex and correlation with seizure development and mental impairment. Am J Neuroradiol 16 (1995) 149-155
95. Smythe J.F., Dyck J.D., Smallhorn J.F., et al. Natural history of cardiac rhabdomyoma in infancy and childhood. Am J Cardiol 66 (1990) 1247-1249
96. Smolarek T.A., Wessner L.L., McCormack F.X., et al. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymphonodes from women with lymphangiomyomatosis. Am J Hum Genet 62 (1998) 810-815
97. Soucek T., Pusch O., Wienecke R., et al. Role of the tuberous sclerosis gene-2 product in cell cycle control. J Biol Chem 272 (1997) 29301-29302
98. Sparagana S.P., Delgado M.R., Batchelor L.L., et al. Seizure remission and antiepileptic drug discontinuation in children with tuberous sclerosis complex. Arch Neurol 60 (2003) 1286-1289
99. Steiner M.S., Goldman S.M., Fishman E.K., et al. The natural history of renal angiomyolipoma. J Urol 150 (1993) 1783-1786
100. Thiele E.A. Managing epilepsy in tuberous sclerosis complex. J Child Neurol 19 (2004) 680-686
101. Tien R.D., Hesselink J.R., and Duberg A. Rare subependymal giant cell astrocytoma in a neonate with tuberous sclerosis. Am J Neuroradiol 11 (1990) 1251-1252
102. Trombley I.K., and Mirra S.S. Ultrastructure of tuberous sclerosis: cortical tuber and subependymal tumor. Ann Neurol 9 (1981) 174-181
103. Van Slegtenhorst M., de Hoogt R., Hermans C., et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277 (1997) 805-808
104. Van Slegtenhorst M., Verhoef S., Tempelaars A., et al. Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: no evidence for genotype-phenotype correlation. J Med Genet 36 (1999) 285-289
105. Vinters H.V., Kerfoot C., Catania M., et al. Tuberous sclerosis-related gene expressions in normal and dysplastic brain. Epilepsy Res 32 (1998) 12-23
106. Vogt H. Zur Diagnostik der tuberosen Sklerose. Zeitschr Erforsch Behandl Jugendl Schwachsinns 2 (1908) 1-16
107. Von Recklinghausen F. Ein Herz von einem Neugeborene welches mehrere Theils nach Aussen, Theils nach den Höhlen prominirende Tumoren (Myomen) trug. Monatschr Geburtsheilkd 20 (1862) 1-2
108. Webb D.W., Thomas R.D., and Osborne J.P. Cardiac rhabdomyomas and their association with tuberous sclerosis. Arch Dis Child 68 (1993) 367-370
109. Weiner D.M., Ewalt D.E., Roach E.S., et al. The tuberous sclerosis complex: a comprehensive review. J Am Coll Surg 187 (1998) 548-561
110. White R., Hua Yue, Scheithauer B., et al. Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers. Ann Neurol 49 (2001) 67-78
111. Wiznitzer M. Autism and tuberous sclerosis. J Child Neurol 19 (2004) 675-679
112. Wolf H.K., Birkholz T., Wellmer J., et al. Neurochemical profile of glioneuronal lesions from patients with pharmacoresistant focal epilepsies. J Neuropathol Exp Neurol 54 (1995) 689-697
113. Yamanouchi H., Jay V., Rutka J.T., et al. Evidence of abnormal differentiation in giant cells of tuberous sclerosis. Pediatr Neurol 17 (1997) 49-53
114. Yates J.R.W., van Bakel I., Sepp T., et al. Female germline mosaicism in tuberous sclerosis confirmed by molecular genetic analysis. Hum Mol Genet 6 (1997) 2265-2269
115. Yeung R.S., Katsetos C.D., and Klein-Szanto. A Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis. Am J Pathol 151 (1997) 1477-1486
116. Young J.M., Burley M.W., Jeremiah S.J., et al. A mutation screen of the TSC1 gene reveals 26 protein truncating mutations and 1 splice site mutation in a panel of 79 tuberous sclerosis patients. Ann Hum Genet 62 (1998) 203-213